Viewing Study NCT00935961

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:58 AM
Ignite Modification Date: 2026-01-28 @ 9:28 AM
Study NCT ID: NCT00935961
Status: COMPLETED
Last Update Posted: 2013-08-09
First Post: 2009-07-07
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: RAD001 (Everolimus) + Docetaxel + Cisplatin as Induction Chemotherapy in Patients With Local-Regional Advanced Head and Neck Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HEAD & NECK Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CISPLATIN View
None RAD001 View
None TAXOTERE (DOCETAXEL) View
None 09-028 View
None Squamous Cell Carcinoma View
None Local-Regional Advanced Head and Neck View